| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.38 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |